Location History:
- Shanghai, CN (2018)
- Beijing, CN (2021)
Company Filing History:
1 out of 2 
1 out of 10 Years Active: 2018-2021
Title: Zhenyuan Miao: Innovator in Medicinal Chemistry
Introduction
Zhenyuan Miao is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have therapeutic potential against toxin exposure and poisoning. With a total of two patents to his name, Miao's work is paving the way for new medical treatments.
Latest Patents
Miao's latest patents include innovative compounds aimed at combating the effects of toxins. The first patent, titled "Nicotinic acid or isonicotinic acid compound and use thereof," discloses a compound that can inhibit toxin endopeptidase activity in vitro. This compound has shown a significant protective effect on mice poisoned with toxins, suggesting its potential use in developing drugs for preventing and treating toxin exposure and poisoning. The second patent, "Mercaptonicotinic acid compound and preparation method and use thereof," presents a class of mercaptonicotinic acid compounds that can inhibit the activity of botulinum toxin and tetanus toxin endopeptidases. This compound also demonstrated a protective effect against botulinum toxin poisoning in mice, indicating its potential for use in medicines aimed at preventing and treating botulism.
Career Highlights
Zhenyuan Miao has worked at esteemed institutions such as the Institute of Microbiology and Epidemiology and the Academy of Military Medical Sciences in China. His research has focused on developing compounds that can mitigate the effects of dangerous toxins, showcasing his commitment to advancing medical science.
Collaborations
Miao has collaborated with notable colleagues, including Hui Wang and Tao Li. These partnerships have likely contributed to the success of his research and patent developments.
Conclusion
Zhenyuan Miao's innovative work in medicinal chemistry highlights his dedication to addressing critical health challenges posed by toxins. His patents represent significant advancements in the field, with the potential to lead to new therapeutic options for toxin exposure and poisoning.